When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - Adamis: An Exciting Pipeline Candidate Moves Forward
Pfizer Inc.
Adamis Pharmaceuticals (ADMP) had a punishing 2018 thanks principally to the persistent delays to the commercialization of Symjepi, its FDA approved epinephrine injector. That drag on the share price is set to be alleviated in 2019 as Symjepi makes its long awaited debut in the market at last. Adamis’ commercial partner Sandoz, the generics subsidiary of Novartis (NVS), will be launching Symjepi early in Q1.
As we discussed in a recent research note, revenues from Symjepi should begin contributing to Adamis’ bottom line by the latter part of 2019. The small